GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ampc ENT385 complex form with ceftazidime

Analyse Crystal structure of ampc ENT385 complex form with ceftazidime in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6LC9
Type
protein
Length
670 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
Ligands
CAZ, SO4
Pockets
7 · best druggability 0.65

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein35738% helix, 23% strand—
BBeta-lactamase (EC 3.5.2.6)protein31341% helix, 25% strand—

Ligands and binding sites

  • CAZ · Acylated ceftazidime · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • DIO · 1,4-diethylene dioxide · additive · 3 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15900.650.7668CAZ, DIO
21570.460.7627GOL
3710.400.8020empty
41140.390.7517empty
51120.380.7424empty

Interfaces

1 interface between chains.

  • A–B · 724 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 6LC9 · Crystal structure of AmpC Ent385 complex form with ceftazidime · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.